724 related articles for article (PubMed ID: 11714065)
1. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
[TBL] [Abstract][Full Text] [Related]
2. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
Bonifaz A; Saúl A
Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
Lebwohl M; Elewski B; Eisen D; Savin RC
Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
[TBL] [Abstract][Full Text] [Related]
5. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study.
Voravutinon V
J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640
[TBL] [Abstract][Full Text] [Related]
6. One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group.
Korting HC; Tietz HJ; Bräutigam M; Mayser P; Rapatz G; Paul C
Med Mycol; 2001 Aug; 39(4):335-40. PubMed ID: 11556763
[TBL] [Abstract][Full Text] [Related]
7. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.
Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B
J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
[TBL] [Abstract][Full Text] [Related]
10. Topical antifungal treatments for tinea cruris and tinea corporis.
El-Gohary M; van Zuuren EJ; Fedorowicz Z; Burgess H; Doney L; Stuart B; Moore M; Little P
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009992. PubMed ID: 25090020
[TBL] [Abstract][Full Text] [Related]
11. A comparison of terbinafine (Lamisil) 1% cream given for one week with clotrimazole (Canesten) 1% cream given for four weeks, in the treatment of tinea pedis.
Evans EG
Br J Dermatol; 1994 Apr; 130 Suppl 43():12-4. PubMed ID: 8186134
[TBL] [Abstract][Full Text] [Related]
12. Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections.
Evans EG; Seaman RA; James IG
Br J Dermatol; 1994 Jan; 130(1):83-7. PubMed ID: 8305323
[TBL] [Abstract][Full Text] [Related]
13. Tinea corporis/cruris: new treatment options.
van Heerden JS; Vismer HF
Dermatology; 1997; 194 Suppl 1():14-8. PubMed ID: 9154395
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.
Rich P; Houpt KR; LaMarca A; Loven KH; Marbury TC; Matheson R; Miller B; Smith S; Wolf J;
Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
Singal A; Pandhi D; Agrawal S; Das S
J Dermatolog Treat; 2005; 16(5-6):331-5. PubMed ID: 16428155
[TBL] [Abstract][Full Text] [Related]
16. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
17. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
Jegasothy BV; Pakes GE
Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
[TBL] [Abstract][Full Text] [Related]
18. Novel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trial.
de Chauvin MF; Viguié-Vallanet C; Kienzler JL; Larnier C
Mycoses; 2008 Jan; 51(1):1-6. PubMed ID: 18076588
[TBL] [Abstract][Full Text] [Related]
19. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
Schäfer-Korting M; Schoellmann C; Korting HC
Skin Pharmacol Physiol; 2008; 21(4):203-10. PubMed ID: 18509254
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
Zaitz C; Ruiz LR; Drullis EM; Gurfinkel P; Ciarnuto MA
Rev Inst Med Trop Sao Paulo; 1990; 32(4):299-303. PubMed ID: 1966257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
